These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11123816)

  • 1. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs.-host disease in Japan.
    Asai T; Inaba S; Ohto H; Osada K; Suzuki G; Takahashi K; Tadokoro K; Minami M
    Transfus Med; 2000 Dec; 10(4):315-20. PubMed ID: 11123816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Institution and significance of the new guidelines for prevention of transfusion associated graft versus host disease].
    Asai T
    Nihon Rinsho; 1997 Sep; 55(9):2296-304. PubMed ID: 9301293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of post-transfusion graft-versus-host disease.
    Tasaki T; Ohto H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):109-11. PubMed ID: 7927133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of post-transfusion graft versus host disease by irradiating blood products with X-ray or gamma-ray].
    Tanaka S
    Nihon Rinsho; 1997 Sep; 55(9):2277-81. PubMed ID: 9301290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of transfusion-associated graft-vs-host disease.
    Holland PV
    Arch Pathol Lab Med; 1989 Mar; 113(3):285-91. PubMed ID: 2645855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-irradiation of blood products following autologous stem cell transplantation: surveillance of the policy of 35 centers.
    Weiss B; Hoffmann M; Anders C; Hellstern P; Schmitz N; Uppenkamp M;
    Ann Hematol; 2004 Jan; 83(1):44-9. PubMed ID: 14551741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
    Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
    Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posttransfusion graft-versus-host disease in Japanese newborns.
    Ohto H; Anderson KC
    Transfusion; 1996 Feb; 36(2):117-23. PubMed ID: 8614960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of risk factors for post-transfusion graft-versus-host disease in Japan. Japanese Red Cross PT-GVHD Study Group.
    Takahashi K; Juji T; Miyamoto M; Uchida S; Akaza T; Tadokoro K; Shibata Y; Ino T; Hidano A
    Lancet; 1994 Mar; 343(8899):700-2. PubMed ID: 7907679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of irradiated blood components: practice parameter.
    Przepiorka D; LeParc GF; Stovall MA; Werch J; Lichtiger B
    Am J Clin Pathol; 1996 Jul; 106(1):6-11. PubMed ID: 8701934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Indications for irradiated blood components: dose and side effects].
    Eiermann TH
    Beitr Infusionsther; 1993; 31():70-3. PubMed ID: 7693267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-associated graft-versus-host disease reexamined: potential for improved prevention using a universally applied intervention.
    Kleinman S; Stassinopoulos A
    Transfusion; 2018 Nov; 58(11):2545-2563. PubMed ID: 30267423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of Irradiation Practice for the Prevention of Transfusion-Associated Graft-versus-Host Disease.
    Pritchard AE; Shaz BH
    Arch Pathol Lab Med; 2016 Oct; 140(10):1092-7. PubMed ID: 27684981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of non-irradiated blood components in Campath (alemtuzumab)-treated renal transplant patients.
    Hui YM; Regan F; Willecombe M; Taube D
    Transfus Med; 2016 Apr; 26(2):138-46. PubMed ID: 26996635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of the treatment strategy for life-threatening hemorrhage in hospitals accredited by the Japanese Society of Anesthesiologists (JSA), and practical use of "Guidelines for Action Against Intraoperative Critical Hemorrhage"].
    Kino S; Inada E; Irita K; Inaba S
    Masui; 2011 Jan; 60(1):5-13. PubMed ID: 21348245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased bacterial infections after transfusion of leukoreduced non-irradiated blood products in recipients of allogeneic stem cell transplants after reduced-intensity conditioning.
    Jaime-Pérez JC; Villarreal-Villarreal CD; Salazar-Riojas R; Méndez-Ramírez N; Vázquez-Garza E; Gómez-Almaguer D
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):526-30. PubMed ID: 25498924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.